PS
GOSS icon

Planning Strategies’s Gossamer Bio GOSS Stock Holding History

Planning Strategies’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455 Buy
+2,764
New +$771 ﹤0.01% 874

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Planning Strategies's GOSS Position: Q2 2026 in Review

Planning Strategies opened a new position in Gossamer Bio (GOSS) in Q2 2026: 2,764 shares worth $455. The stake represents ﹤0.01% of the portfolio and ranks #874 among its holdings.

155 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Planning Strategies held 2,764 shares of Gossamer Bio worth $455 as of Q2 2026.
  • Gossamer Bio was a new Planning Strategies position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Planning Strategies's portfolio in Q2 2026, its #874 holding.
  • 155 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Planning Strategies's 13F filing for Q2 2026, filed 27 Jul 2026.